Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,677,942
+$2,920,643 QoQ
Shares Held
1,456,851
-34.3% QoQ
Ownership
0.965%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. BHVN ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in BHVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,677,942 | 1,456,851 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,757,299 | 2,217,175 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,789,429 | 2,018,550 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,164,260 | 2,009,611 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,746,125 | 3,171,235 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,864,294 | 2,822,974 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $127,445,333 | 3,412,191 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $171,823,143 | 3,438,526 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $114,004,265 | 3,284,479 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $183,048,632 | 3,347,022 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $134,149,024 | 3,134,323 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $60,945,122 | 2,343,142 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $52,079,006 | 2,177,216 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,469,893 | 1,644,941 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,268,910 | 1,316,204 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||